Back
Incyte Vs. Syndax Pharmaceuticals Industry Stock Comparison
Sell
46
INCY
Incyte
Last Price:
70.17
Seasonality Move:
50.43%
Sell
23
SNDX
Syndax Pharmaceuticals
Last Price:
15.12
Seasonality Move:
13.57%
Sell
46
Incyte (INCY)
is a Sell
Is Incyte a Buy, Sell or Hold?
- The current Incyte [INCY] share price is $71.05. The Score for INCY is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- INCY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $15.95. The Score for SNDX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- SNDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INCY Stock Price Chart
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $15.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing slight buying pressure.
INCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.74 | Buy |
| Relative Strength Index (14 RSI): | 43.55 | Sell |
| Chaikin Money Flow: | 254620 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.22 - 79.72) | Sell |
| Bollinger Bands (100): | (60.93 - 72.05) | Buy |
SNDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.83 | Sell |
| Relative Strength Index (14 RSI): | 35.07 | Sell |
| Chaikin Money Flow: | 549224 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.88 - 20.56) | Sell |
| Bollinger Bands (100): | (17.97 - 22.01) | Sell |
INCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 76.85 | Sell |
| 20-day SMA: | 75.41 | Sell |
| 50-day SMA: | 69.53 | Buy |
| 200-day SMA: | 61.95 | Buy |
| 8-day EMA: | 75.23 | Sell |
| 20-day EMA: | 74.74 | Sell |
| 50-day EMA: | 70.95 | Buy |
| 200-day EMA: | 64.62 | Buy |
SNDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.89 | Sell |
| 20-day SMA: | 18.56 | Sell |
| 50-day SMA: | 18.68 | Sell |
| 200-day SMA: | 20.83 | Sell |
| 8-day EMA: | 16.88 | Sell |
| 20-day EMA: | 18.02 | Sell |
| 50-day EMA: | 18.8 | Sell |
| 200-day EMA: | 19.91 | Sell |
Incyte Earnings Growth & INCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.29 per share, and an increase next year of $4.72 per share.
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and a decrease next year of $1.20 per share.
Incyte Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Syndax Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||